The overlay goals, tied to the ordered parameters above, are:
Glucose is maintained within the patient’s individualized ordered range, without severe hypoglycemic or hyperglycemic events.
Insulin, injectable- or oral-agent, and monitoring technique are correct on observation, so the regimen is actually delivered.
The patient and caregiver recognize and treat hypoglycemia — including glucagon where ordered — and follow the sick-day rules.
The feet are protected, with skin integrity and protective-sensation status checked each visit and any change reported.
Glycemic control improves toward the individualized target over the episode of care, with the A1c trend documented, and complications and readmissions decrease.
